Ive never needed an answer to this question becaus
Post# of 22465
(Total Views: 477)
Posted On: 02/24/2021 2:41:16 PM
Ive never needed an answer to this question because when I bought this stock, I did so because of QD production and licensing program that was being set up in India. COVID wasn’t even a gleam in China’s eye at that point. Now that my stock value has increased by a multiple of 5 solely on the prospects of a suite of COVID-related products ands services, I have to make a decision about how much I believe in this. Some here treat QTMM riches as an article of faith, stoning blasphemers who simply want to understand this investment in order to make informed decisions. Let those people throw stones. You cant stop them anyway. But I would like to hear from others about the following:
How will Health ID be monetized? I see nothing that indicates that QTMM will be taking a piece of Innova’s test sales revenues. Discussion of using quantum dots as a test ingredient is interesting, but I’ve seen no deal where that has been authorized by the FDA or any other regulatory agency from another country, is part of a development deal between QTMM and Innova, or is anywhere near being submitted for approval. So, will Health ID be charging for its app? Will it be charging the end user, the test manufacturer, the government, or come combination of the three?
Assuming the sole source of QTMM revenue in the short to medium term is the app, how will the Health ID app achieve market penetration so as to start earning revenue, considering that Microsoft and the tech giants have already announced their intentions to get in on the health tracking/passport game and considering that Health ID is not available on Apple’s App Store (though if you search for “COVID test,” you will see a slew of apps listed).
I think “I don’t know” is a perfectly acceptable answer to each of these questions AT THIS PHASE OF THE GAME. I at least like to proceed with the understanding that i don’t know, that i need to know, and put the request out there so someday, when it is no longer acceptable to simply assume, actual information might be supplied.
While “I don’t know” is a perfectly acceptable answer, “why don’t you sell your a stock if you don’t like it” is not. That’s just applying the type of pressure that bubbles are made of. Same with “For the love of God, how many times do we have to tell you?” Those are responses that implement a tactic, but they aren’t answers.
How will Health ID be monetized? I see nothing that indicates that QTMM will be taking a piece of Innova’s test sales revenues. Discussion of using quantum dots as a test ingredient is interesting, but I’ve seen no deal where that has been authorized by the FDA or any other regulatory agency from another country, is part of a development deal between QTMM and Innova, or is anywhere near being submitted for approval. So, will Health ID be charging for its app? Will it be charging the end user, the test manufacturer, the government, or come combination of the three?
Assuming the sole source of QTMM revenue in the short to medium term is the app, how will the Health ID app achieve market penetration so as to start earning revenue, considering that Microsoft and the tech giants have already announced their intentions to get in on the health tracking/passport game and considering that Health ID is not available on Apple’s App Store (though if you search for “COVID test,” you will see a slew of apps listed).
I think “I don’t know” is a perfectly acceptable answer to each of these questions AT THIS PHASE OF THE GAME. I at least like to proceed with the understanding that i don’t know, that i need to know, and put the request out there so someday, when it is no longer acceptable to simply assume, actual information might be supplied.
While “I don’t know” is a perfectly acceptable answer, “why don’t you sell your a stock if you don’t like it” is not. That’s just applying the type of pressure that bubbles are made of. Same with “For the love of God, how many times do we have to tell you?” Those are responses that implement a tactic, but they aren’t answers.
(2)
(0)